Compare DERM & RGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DERM | RGCO |
|---|---|---|
| Founded | 2014 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 225.0M |
| IPO Year | 2021 | 2005 |
| Metric | DERM | RGCO |
|---|---|---|
| Price | $6.19 | $21.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $13.75 | N/A |
| AVG Volume (30 Days) | ★ 175.0K | 9.7K |
| Earning Date | 11-11-2026 | 11-18-2026 |
| Dividend Yield | N/A | ★ 4.02% |
| EPS Growth | ★ 34.72 | 11.21 |
| EPS | N/A | ★ 1.37 |
| Revenue | $61,858,000.00 | ★ $95,334,212.00 |
| Revenue This Year | $31.55 | $15.70 |
| Revenue Next Year | $60.28 | $4.44 |
| P/E Ratio | ★ N/A | $15.80 |
| Revenue Growth | 10.20 | ★ 12.63 |
| 52 Week Low | $4.31 | $20.55 |
| 52 Week High | $9.56 | $27.17 |
| Indicator | DERM | RGCO |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 46.93 |
| Support Level | $5.95 | $20.86 |
| Resistance Level | $6.59 | $22.21 |
| Average True Range (ATR) | 0.41 | 0.51 |
| MACD | -0.07 | 0.06 |
| Stochastic Oscillator | 9.18 | 48.63 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.